• Like
  • Save
The Future of Oncology Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
Upcoming SlideShare
Loading in...5
×

The Future of Oncology Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis

  • 248 views
Uploaded on

SummaryThe author has released its latest research 'The Future of Oncology Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis.' The report provides …

SummaryThe author has released its latest research 'The Future of Oncology Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis.' The report provides in-depth analysis of unmet needs, drivers and barriers that impact the global oncology therapeutics market. The report analyzes the markets for oncology therapeutics in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns, sales, price and volume are forecast until 2015 for the key geographies as well as the leading therapeutic segments. Further, the report provides competitive benchmarking for the leading companies and also analyzes the mergers, acquisitions and licensing agreements that shape the global markets.This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.ScopeThe scope of this report includes:- Annualized market data for the oncology therapeutics market from 2000 to 2008, forecast forward to 2015- Analysis of the leading therapeutic segments including lung cancer, breast cancer, prostate cancer, colorectal cancer and Non-Hodgkin's Lymphoma.- Analysis of the oncology diseases therapeutics market in the leading geographies of the world, which include the US, the UK, Germany, France, Italy, Spain, and Japan - Market characterization of the oncology therapeutics market including market size, annual cost of therapy, sales volume and treatment usage patterns - Key drivers and barriers that have a significant impact on the market - Coverage of pipeline molecules in various phases of drug development - Competitive benchmarking of leading companies. The key companies studied in this report are F.Hoffmann-La Roche, Novartis AG, Sanofi-aventis, Amgen, AstraZeneca, Merck & Co, Pfizer Inc, Celgene Corporation, Bristol-Myers Squibb and Eli Lilly- Key M&A activities, licensing agreements, that have taken place between 2008 and 2009 in the global oncology therapeutics marketReasons to buyThe report will enhance your decision making capability. It will allow you to- Align product portfolio to the markets with high growth potential- Develop market-entry and market expansion strategies by identifying the leading therapeutic segments and geographic markets poised for strong growth - Reinforce R&D pipelines by identifying new target mechanisms which can produce first in class molecules with more efficiency and better safety- Develop key strategic initiatives by understanding key focus areas of leading companies - Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps

  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
248
On Slideshare
0
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
0
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!The Future of Oncology Therapeutics - Market Forecasts to 2015,Competitive Benchmarking, Product Pipeline and Deals AnalysisPublished on December 2009 Report SummarySummaryThe author has released its latest research The Future of Oncology Therapeutics - Market Forecasts to 2015, CompetitiveBenchmarking, Product Pipeline and Deals Analysis. The report provides in-depth analysis of unmet needs, drivers and barriers thatimpact the global oncology therapeutics market. The report analyzes the markets for oncology therapeutics in the US, the top fivecountries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns, sales, price and volume areforecast until 2015 for the key geographies as well as the leading therapeutic segments. Further, the report provides competitivebenchmarking for the leading companies and also analyzes the mergers, acquisitions and licensing agreements that shape the globalmarkets.This report is built using data and information sourced from proprietary databases, primary and secondary research and in-houseanalysis by GBI Researchs team of industry experts.ScopeThe scope of this report includes:- Annualized market data for the oncology therapeutics market from 2000 to 2008, forecast forward to 2015- Analysis of the leading therapeutic segments including lung cancer, breast cancer, prostate cancer, colorectal cancer andNon-Hodgkins Lymphoma.- Analysis of the oncology diseases therapeutics market in the leading geographies of the world, which include the US, the UK,Germany, France, Italy, Spain, and Japan- Market characterization of the oncology therapeutics market including market size, annual cost of therapy, sales volume andtreatment usage patterns- Key drivers and barriers that have a significant impact on the market- Coverage of pipeline molecules in various phases of drug development- Competitive benchmarking of leading companies. The key companies studied in this report are F.Hoffmann-La Roche, Novartis AG,Sanofi-aventis, Amgen, AstraZeneca, Merck & Co, Pfizer Inc, Celgene Corporation, Bristol-Myers Squibb and Eli Lilly- Key M&A activities, licensing agreements, that have taken place between 2008 and 2009 in the global oncology therapeutics marketReasons to buyThe report will enhance your decision making capability. It will allow you to- Align product portfolio to the markets with high growth potential- Develop market-entry and market expansion strategies by identifying the leading therapeutic segments and geographic marketspoised for strong growth- Reinforce R&D pipelines by identifying new target mechanisms which can produce first in class molecules with more efficiency andbetter safety- Develop key strategic initiatives by understanding key focus areas of leading companies- Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gapsThe Future of Oncology Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis Page 1/12
  • 2. Find Industry reports, Company profilesReportLinker and Market Statistics Table of Content1 Table of Contents1 Table of Contents 41.1 List of Tables 81.2 List of Figures 102 Global Oncology Therapeutics Market: Introduction 132.1 GBI Research Report Guidance 143 Global Oncology Therapeutics Market: Cancer Epidemiology 154 Global Oncology Therapeutics Market: Market Overview 164.1 Introduction 164.2 Revenue Forecasts for the Global Oncology Therapeutics Market 184.2.1 Sales Value 184.2.2 Sales Volume 194.2.3 Drug Prices 204.2.4 Treatment Usage Patterns 214.3 Generics in Oncology Therapeutics Market 254.4 Oncology therapeutics market Drivers 264.4.1 Steady Increase in the Ageing Population 264.4.2 New Innovative Products in the Pipeline 274.4.3 Rapid Uptake of Targeted Therapies in Key Cancer Indications 274.5 Oncology Therapeutics Market Restraints 274.5.1 The US Cancer Incidence Moving Towards a Decelerating Growth Rate 274.5.2 Patent Expirations and Entry of Generics Pose as a Severe Threat for Primary Manufacturers 284.5.3 Restrictive Pricing and Reimbursement Policies Causing Serious Problems in the Oncology Therapeutics Market Growth 294.5.4 More Than 80 Molecules to be Launched Over the Next Seven years - Leading to More Competition 305 Global Oncology Therapeutics Market: Pricing and Reimbursement 315.1 Average Cost of Drug Treatment 315.2 The US 335.2.1 Pricing 335.2.2 Medicare Reimbursement on Cancer Drugs 335.3 Europe 345.3.1 Pricing and Reimbursement - Country Analysis 366 Global Oncology Therapeutics Market: Geographical Landscape 416.1 Geographic Break-up 416.2 The US 426.2.1 Sales Value 426.2.2 Sales Volume 436.2.3 Drug Prices 446.2.4 Treatment Usage Patterns 456.3 Top Five European Countries 496.3.1 Sales Value 496.3.2 Sales Volume 516.3.3 Drug Prices 516.3.4 Treatment Usage Patterns 536.4 Japan 57The Future of Oncology Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis Page 2/12
  • 3. Find Industry reports, Company profilesReportLinker and Market Statistics6.4.1 Sales Value 576.4.2 Sales Volume 586.4.3 Drug Prices 596.4.4 Treatment Usage Patterns 607 Global Oncology Therapeutics Market: Therapeutic Landscape 657.1 Breast Cancer Therapeutics Market 657.1.1 Introduction 657.1.2 Sales Value 677.1.3 Sales Volume 687.1.4 Drug Prices 697.1.5 Treatment Usage Patterns 707.2 Non-Hodgkins Lymphoma Therapeutics Market 757.2.1 Introduction 757.2.2 Sales Value 767.2.3 Sales Volume 787.2.4 Drug Prices 787.2.5 Treatment Usage Patterns 797.3 Colorectal Cancer Therapeutics Market 837.3.1 Introduction 837.3.2 Sales Value 877.3.3 Sales Volume 887.3.4 Drug Prices 897.3.5 Treatment Usage Patterns 907.4 Prostate Cancer Therapeutics Market 947.4.1 Introduction 947.4.2 Sales Value 967.4.3 Sales Volume 977.4.4 Drug Prices 987.4.5 Treatment Usage Patterns 997.5 Lung Cancer Therapeutics Market 1037.5.1 Introduction 1037.5.2 Sales Value 1077.5.3 Sales Volume 1087.5.4 Drug Prices 1097.5.5 Treatment Usage Patterns 1098 Global Oncology Therapeutics Market: Pipeline Analysis 1158.1 Introduction 1158.1.1 R&D Strategies 1168.2 R&D Trends 1178.2.1 Discovery of Unknown Mutations that Play Key Role in Cancers 1178.2.2 Pairing Therapeutics and Diagnostics 1188.3 Profiles of Key Late-Stage Drugs 1198.3.1 Angiogenesis and Multi-Targeted Kinase Inhibitors 1198.3.2 Hsp90 Inhibitors 1218.3.3 Insulin-like Growth Factor Receptor Inhibitors 1228.3.4 Hedgehog Inhibitors 1248.3.5 Immuno-conjugates 1248.4 Insights into Most Promising Drugs 1258.4.1 Provenge 1258.4.2 Denosumab 127The Future of Oncology Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis Page 3/12
  • 4. Find Industry reports, Company profilesReportLinker and Market Statistics8.4.3 Tasigna 1298.4.4 Aflibercept 1308.4.5 Tykerb 1319 Global Oncology Therapeutics Market: Competitive Landscape 1349.1 Evolving competitive landscape 1349.1.1 Major players 1359.1.2 Key areas focused for R&D 1359.1.3 Challenges faced by brands in marketing the oncology products 1369.2 Market Share Analysis 1389.2.1 Rituxan, Avastin, Revlimid and Herceptin are expected to lead the market through 2015 1399.3 Roche/Genentech 1419.3.1 Key Oncology Drugs 1429.3.2 Key Indications of Interest 1459.3.3 Pipeline Analysis 1469.3.4 Key Strategies 1489.4 Novartis 1489.4.1 Key Oncology Drugs 1499.4.2 Key Indications of Interest 1529.4.3 Pipeline Analysis 1529.4.4 Key Strategies 1539.5 Sanofi-Aventis 1559.5.1 Key Oncology Drugs 1569.5.2 Key Indications of Interest 1579.5.3 Pipeline Analysis 1589.5.4 Key Strategies 1599.6 Amgen 1609.6.1 Key Oncology Drugs 1619.6.2 Key of Indications of Interests 1639.6.3 Pipeline Analysis 1639.6.4 Key Strategies 1659.7 Astra Zeneca 1659.7.1 Key Oncology Drugs 1669.7.2 Key Indications of Interests 1679.7.3 Pipeline Analysis 1689.7.4 Key Strategies 16910 . Global Oncology Therapeutics Market: M&A Landscape 17010.1 Overview 17010.1.1 Pfizer Acquires Wyeth 17010.1.2 Roche Acquires Genentech 17010.1.3 Takeda Pharmaceutical Acquires IDM Pharma 17110.1.4 EUS Pharma Acquires Cytogen Corporation 17110.1.5 GlaxoSmithKline Acquires Sirtris Pharmaceuticals 17110.1.6 GlaxoSmithKline Acquires Bristol-Myers Squibb (Egyptian unit) 17110.1.7 Pfizer Enters into an Agreement with Aurobindo Pharma and Claris Life Sciences 17110.1.8 Teva Pharmaceuticals Acquires Barr 17110.1.9 Sanofi-Aventis Acquires Medley 17110.2 R&D Licensing Agreements 17110.2.1 Deals by Phase 17210.2.2 Deals by Geography 17210.2.3 Deals by Licensing Type 173The Future of Oncology Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis Page 4/12
  • 5. Find Industry reports, Company profilesReportLinker and Market Statistics10.2.4 Deals by Value ($) 17410.2.5 Preclinical 17410.2.6 Phase I 17610.2.7 Phase II 17710.2.8 Phase III 17810.2.9 Approved 18011 . Global Oncology Therapeutics Market: Appendix 18211.1 Research Methodology 18211.2 Geographical Scope 18211.3 Coverage 18211.4 Secondary Research 18311.5 Primary Research 18311.6 Models 18311.7 Forecasts 18411.8 Expert Panel Validation 18411.9 Contact Us 18411.10 Disclaimer 1841.1 List of TablesTable 1: Oncology Therapeutics Market, Global, Revenue Forecasts ($ m), 2000-2008 17Table 2: Oncology Therapeutics Market, Global, Revenue Forecasts ($ m), 2008-2015 17Table 3: Oncology Therapeutics Market, Global, Sales Volume (million), 2000-2008 18Table 4: Oncology Therapeutics Market, Global, Sales Volume (million), 2009-15 18Table 5: Oncology Therapeutics Market, Global, Average Cost per Dose ($), 2000-2008 19Table 6: Oncology Therapeutics Market, Global, Average Cost per Dose ($), 2008-2015 19Table 7: Oncology Therapeutics Market, Global, Treatment Usage Patterns, Historic 2000-2008 20Table 8: Oncology Therapeutics Market, Global, Treatment Usage Patterns, Forecasts 2008-2015 21Table 9: Oncology Therapeutics Market, Global, Generics Sales Forecast, 2008-2015 25Table 10: Oncology Therapeutics Market, The US, Major Drug Patent Expirations, 2009-19 28Table 11: Oncology Therapeutics, Global, Annual Cost of Therapy ($), 2000-2008 31Table 12: Oncology Therapeutics, Global, Annual Cost of Therapy ($), 2008-2015 31Table 13: Direct Medical Costs for Cancer Care in Select European Countries 2008 33Table 14: Reimbursement Rates based on Pharamco-economic Evaluation 2008 37Table 15: Italy Reimbursement Coverage System 2008 38Table 16: Spain Pharmaceutical Pricing System 2008 39Table 17: Italy Reimbursement Coverage System 2008 39Table 18: Oncology Therapeutics Market, Global, Revenue Break-up by Geography ($ m), 2000-2008 40Table 19: Oncology Therapeutics Market, Global, Revenue Break-up by Geography ($ m), 2008-2015 41Table 20: Oncology Therapeutics Market, The US, Revenue Forecasts ($ m), 2000-2008 42Table 21: Oncology Therapeutics Market, The US, Revenue Forecasts ($ m), 2008-2015 42Table 22: Oncology Therapeutics Market, The US, Volume Forecasts (million), 2000-2008 43Table 23: Oncology Therapeutics Market, The US, Volume Forecasts (million), 2008-2015 43Table 24: Oncology Therapeutics Market, The US, Average Cost per Dose ($), 2000-2008 44Table 25: Oncology Therapeutics Market, The US, Average Cost per Dose ($), 2008-2015 44Table 26: Oncology Therapeutics Market, The US, Treatment Usage Patterns, 2000-2008 45Table 27: Oncology Therapeutics Market, The US, Treatment Usage Patterns, 2008-2015 45Table 28: Oncology Therapeutics Market, Europe, Revenue Forecasts ($ m), 2000-2008 49Table 29: Oncology Therapeutics Market, Europe, Revenue Forecasts ($ m), 2008-2015 49Table 30: Oncology Therapeutics Market, Europe, Volume Forecasts (million), 2000-2008 50The Future of Oncology Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis Page 5/12
  • 6. Find Industry reports, Company profilesReportLinker and Market StatisticsTable 31: Oncology Therapeutics Market, Europe, Volume Forecasts (million), 2008-2015 50Table 32: Oncology Therapeutics Market, Europe, Average Cost per Dose ($), 2000-2008 51Table 33: Oncology Therapeutics Market, Europe, Average Cost per Dose ($), 2008-2015 52Table 34: Oncology Therapeutics Market, Europe, Treatment Usage Patterns, 2000-2008 52Table 35: Oncology Therapeutics Market, Europe, Treatment Usage Patterns, 2008-2015 53Table 36: Oncology Therapeutics Market, Japan, Revenue ($ bn), 2000-2008 57Table 37: Oncology Therapeutics Market, Japan, Revenue ($ bn), 2008-2015 57Table 38: Oncology Therapeutics Market, Japan, Volume Forecasts (million), 2000-2008 58Table 39: Oncology Therapeutics Market, Japan, Volume Forecasts (million), 2008-2015 58Table 40: Oncology Therapeutics Market, Japan, Average Cost per Dose ($), 2000-2008 59Table 41: Oncology Therapeutics Market, Japan, Average Cost per Dose ($), 2009-15 59Table 42: Oncology Therapeutics Market, Japan, Treatment Usage Patterns, 2000-2008 60Table 43: Oncology Therapeutics Market, Japan, Treatment Usage Patterns, 2008-2015 60Table 44: Breast Cancer Therapeutics Market, Global, Cancer Categorized by Disease Stage 65Table 45: Breast Cancer Therapeutics Market, Global, Revenue ($ bn), 2000-2008 67Table 46: Breast Cancer Therapeutics Market, Global, Revenue ($ bn), 2008-2015 67Table 47: Breast Cancer Therapeutics Market, Global, Volume (million), 2000-2008 68Table 48: Breast Cancer Therapeutics Market, Global, Volume (million), 2008-2015 68Table 49: Breast Cancer Therapeutics Market, Global, Average Cost per Dose ($), 2000-2008 69Table 50: Breast Cancer Therapeutics Market, Global, Average Cost per Dose ($), 2008-2015 69Table 51: Breast Cancer Therapeutics Market, Global, Usage Patterns, 2000-2008 70Table 52: Breast Cancer Therapeutics Market, Global, Usage Patterns, 2008-2015 71Table 53: Non-Hodgkins Lymphoma Therapeutics Market, Global, Cancer Categorized by Disease Stage 74Table 54: Non-Hodgkins Lymphoma Therapeutics Market, Global, Revenue ($ bn), 2000-2008 76Table 55: Non-Hodgkins Lymphoma Therapeutics Market, Global, Revenue ($ bn), 2008-2015 76Table 56: Non-Hodgkins Lymphoma Therapeutics Market, Global, Volume (million), 2000-2008 77Table 57: Non-Hodgkins Lymphoma Therapeutics Market, Global, Volume (million), 2008-2015 77Table 58: Non-Hodgkins Lymphoma Therapeutics Market, Global, Average Cost per Dose ($), 2000-2008 78Table 59: Non-Hodgkins Lymphoma Therapeutics Market, Global, Average Cost per Dose ($), 2008-2015 78Table 60: Non-Hodgkins Lymphoma Therapeutics Market, Global, Usage Patterns, 2000-2008 79Table 61: Non-Hodgkins Lymphoma Therapeutics Market, Global, Usage Patterns, 2008-2015 80Table 62: Colorectal Cancer Therapeutics Market, Global, Cancer Categorized by Disease Stage 84Table 63: Colorectal Cancer Therapeutics Market, Global, Revenue ($ bn), 2000-2008 86Table 64: Colorectal Cancer Therapeutics Market, Global, Revenue ($ bn), 2008-2015 86Table 65: Colorectal Cancer Therapeutics Market, Global, Volume (million), 2000-2008 87Table 66: Colorectal Cancer Therapeutics Market, Global, Volume (million), 2008-2015 87Table 67: Colorectal Cancer Therapeutics Market, Global, Average Cost per Dose ($), 2000-2008 88Table 68: Colorectal Cancer Therapeutics Market, Global, Average Cost per Dose ($), 2008-2015 88Table 69: Colorectal Cancer Therapeutics Market, Global, Usage Patterns, 2000-2008 90Table 70: Colorectal Cancer Therapeutics Market, Global, Usage Patterns, 2008-2015 90Table 71: Prostate Cancer Therapeutics Market, Global, Cancer Categorized by Disease Stage 94Table 72: Prostate Cancer Therapeutics Market, Global, Revenue ($ bn), 2000-2008 96Table 73: Prostate Cancer Therapeutics Market, Global, Revenue ($ bn), 2008-2015 96Table 74: Prostate Cancer Therapeutics Market, Global, Volume (million), 2000-2008 96Table 75: Prostate Cancer Therapeutics Market, Global, Volume (million), 2008-2015 97Table 76: Prostate Cancer Therapeutics Market, Global, Average Cost per Dose ($), 2000-2008 97Table 77: Prostate Cancer Therapeutics Market, Global, Average Cost per Dose ($), 2008-2015 98Table 78: Prostate Cancer Therapeutics Market, Global, Usage Patterns, 2000-2008 99Table 79: Prostate Cancer Therapeutics Market, Global, Usage Patterns, 2008-2015 99Table 80: Lung Cancer Therapeutics Market, Global, Cancer Categorized by Disease Stage 103The Future of Oncology Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis Page 6/12
  • 7. Find Industry reports, Company profilesReportLinker and Market StatisticsTable 81: Lung Cancer Therapeutics Market, Global, NSCLC Treatment by Stage of the Disease 105Table 82: Lung Cancer Therapeutics Market, Global, Revenue ($ bn), 2000-2008 106Table 83: Lung Cancer Therapeutics Market, Global, Revenue ($ bn), 2008-2015 107Table 84: Lung Cancer Therapeutics Market, Global, Volume (million), 2000-2008 107Table 85: Lung Cancer Therapeutics Market, Global, Volume (million), 2008-2015 107Table 86: Lung Cancer Therapeutics Market, Global, Average Cost per Dose ($), 2000-2008 108Table 87: Lung Cancer Therapeutics Market, Global, Average Cost per Dose ($), 2008-2015 108Table 88: Lung Cancer Therapeutics Market, Global, Usage Patterns, 2000-2008 110Table 89: Lung Cancer Therapeutics Market, Global, Usage Patterns, 2008-2015 110Table 90: Oncology Therapeutics Market, Global, Top 10 Brands Sales ($ m), 2006-2008 139Table 91: Oncology Therapeutics Market, Global, Roche/Genentech Sales, 2006-2015 141Table 92: Oncology Therapeutics Market, Global, Novartis, Sales ($ m), 2006-2015 148Table 93: Oncology Therapeutics Market, Global, Sanofi-Aventis, Sales ($ m), 2006-15 155Table 94: Oncology Therapeutics Market, Global, Amgen, Sales ($ m), 2006-2015 160Table 95: Oncology Therapeutics Market, Global, AstraZeneca, Sales ($ m), 2006-2015 165Table 96: Oncology Therapeutics Market, Global, Licensing Agreements for Drugs in the Preclinical Stage, 2008-09 174Table 97: Oncology Therapeutics Market, Global, Licensing Agreements for Drugs in the Phase I, 2008-09 175Table 98: Oncology Therapeutics Market, Global, Licensing Agreements for Drugs in the Phase II, 2008-09 176Table 99: Oncology Therapeutics Market, Global, Licensing Agreements for Drugs in the Phase III, 2008-09 178Table 100: Oncology Therapeutics Market, Global, Licensing Agreements for Approved Drugs, 2008-09 1791.2 List of FiguresFigure 1: Global Cancer Incidence by Tumor Type 2007 15Figure 2: Global Cancer Mortality by Tumor Type 2007 15Figure 3: Oncology Therapeutics Market, Global, Drivers and Restraints, 2008 16Figure 4: Oncology Therapeutics Market, Global, Revenue Forecasts ($ m), 2000-2015 17Figure 5: Oncology Therapeutics Market, Global, Sales Volume (million), 2000-2015 18Figure 6: Oncology Therapeutics Market, Global, Average Cost per Dose ($), 2000-2015 19Figure 7: Oncology Therapeutics Market, Global, Treatment Usage Patterns, 2000-2015 20Figure 8: Oncology Therapeutics Market, Global, Diseased Population, 2000-2015 21Figure 9: Oncology Therapeutics Market, Global, Treatment Seeking Population, 2000-2015 22Figure 10: Oncology Therapeutics Market, Global, Diagnosis Population, 2000-2015 23Figure 11: Oncology Therapeutics Market, Global, Prescription Population, 2000-2015 24Figure 12: Oncology Therapeutics Market, Global, Generics Sales Forecast, 2008-2015 24Figure 13: Oncology Therapeutics Market, Global, Drivers and Restraints, 2008-2015 25Figure 14: Oncology Therapeutics Market, Global, Future Drivers and Restraints of the market, 2015 29Figure 15: Oncology Therapeutics, Global, Annual Cost of Therapy ($), 2000-2015 31Figure 16: Oncology Therapeutics, The US, Cost of Treatment ($), 2000-2015 32Figure 17: Pricing and Reimbursement Trends of Top Five Countries in the EU 2008 34Figure 18: Oncology Therapeutics, Top Five Countries in the EU , Cost of Treatment ($), 2000-2015 34Figure 19: UK NICE Patients Access Schemes by Type 36Figure 20: Oncology Therapeutics Market, Global, Revenue Break-up by Geography ($ m), 2000-2015 40Figure 21: Oncology Therapeutics Market, Global, Segmentation by Geography 2008 & 2015 41Figure 22: Oncology Therapeutics Market, The US, Revenue Forecasts ($ m), 2000-2015 42Figure 23: Oncology Therapeutics Market, The US, Volume Forecasts (million), 2000-2015 43Figure 24: Oncology Therapeutics Market, The US, Average Cost per Dose ($), 2000-2015 44Figure 25: Oncology Therapeutics Market, The US, Treatment Usage Patterns, 2000-2015 45Figure 26: Oncology Therapeutics Market, the US, Diseased Population, 2000-2015 46Figure 27: Oncology Therapeutics Market, the US, Treatment Seeking Population, 2000-2015 46The Future of Oncology Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis Page 7/12
  • 8. Find Industry reports, Company profilesReportLinker and Market StatisticsFigure 28: Oncology Therapeutic Market, The US, Diagnosis Population, 2000-2015 47Figure 29: Oncology Therapeutic Market, The US, Prescription Population, 2000-2015 48Figure 30: Oncology Therapeutics Market, The US, Drivers and Restraints 48Figure 31: Oncology Therapeutics Market, Europe, Revenue Forecasts ($ m), 2000-2015 49Figure 32: Oncology Therapeutics Market, Europe, Volume Forecasts (million), 2000-2015 50Figure 33: Oncology Therapeutics Market, Europe, Average Cost per Dose ($), 2000-2015 51Figure 34: Oncology Therapeutics Market, Europe, Treatment Usage Patterns, 2000-2015 52Figure 35: Oncology Therapeutics Market, Europe, Diseased Population, 2000-2015 53Figure 36: Oncology Therapeutics Market, Europe, Treatment Seeking Population, 2000-2015 54Figure 37: Oncology Therapeutics Market, Europe, Diagnosis Population, 2000-2015 54Figure 38: Oncology Therapeutics Market, Europe, Prescription Population, 2000-2015 55Figure 39: Oncology Therapeutics Market, Europe, Drivers and Restraints, 2008-2015 56Figure 40: Oncology Therapeutics Market, Japan, Revenue ($ bn), 2000-2015 57Figure 41: Oncology Therapeutics Market, Japan, Volume Forecasts (million), 2000-2015 58Figure 42: Oncology Therapeutics Market, Japan, Average Cost per Dose ($), 2000-2015 59Figure 43: Oncology Therapeutics Market, Japan, Treatment Usage Patterns, 2000-2015 60Figure 44: Oncology Therapeutics Market, Japan, Diseased Population, 2000-2015 61Figure 45: Oncology Therapeutics Market, Japan, Treatment Seeking Population, 2000-2015 61Figure 46: Oncology Therapeutics Market, Japan, Diagnosis Population, 2000-2015 62Figure 47: Oncology Therapeutics Market, Japan, Prescription Population, 2000-2015 63Figure 48: Oncology Therapeutics Market, Global, Market Share of Major Indications, 2008 64Figure 49: Breast Cancer Therapeutics Market, Global, Revenue Forecasts ($ m), 2000-2015 67Figure 50: Breast Cancer Therapeutics Market, Global, Volume (million), 2000-2015 68Figure 51: Breast Cancer Therapeutics Market, Global, Average Cost per Dose ($), 2000-2015 69Figure 52: Breast Cancer Therapeutics Market Major Drivers and Restraints 2008-2015 70Figure 53: Breast Cancer Therapeutics Market, Global, Usage Patterns, 2000-2015 70Figure 54: Breast Cancer Therapeutics Market, Global, Diseased Population, 2008-2015 71Figure 55: Breast Cancer Therapeutics Market, Global, Treatment Seeking Population, 2000-2015 72Figure 56: Breast Cancer Therapeutics Market, Global, Diagnosis Population, 2000-2015 73Figure 57: Breast Cancer Therapeutics Market, Global, Prescription Population, 2000-2015 73Figure 58: Non-Hodgkins Lymphoma Therapeutics Market, Global, Revenue Forecasts ($ m), 2000-2015 76Figure 59: Non-Hodgkins Lymphoma Therapeutics Market, Global, Volume (million), 2000-2015 77Figure 60: Non-Hodgkins Lymphoma Therapeutics Market, Global, Average Cost per Dose ($), 2000-2015 78Figure 61: Non-Hodgkins Lymphoma Therapeutics Market, Global, Drivers and Restraints, 2008-2015 79Figure 62: Non-Hodgkins Lymphoma Therapeutics Market, Global, Usage Patterns, 2000-2015 79Figure 63: Non-Hodgkins Lymphoma Therapeutics Market, Global, Diseased Population, 2000-2015 80Figure 64: Non-Hodgkins Lymphoma Therapeutics Market, Global, Treatment Seeking Population, 2000-2015 81Figure 65: Non-Hodgkins Lymphoma Therapeutics Market, Global, Diagnosis Population, 2000-2015 81Figure 66: Non-Hodgkins Lymphoma Therapeutics Market, Global, Prescription Population, 2000-2015 82Figure 67: Colorectal Cancer Therapeutics Market, Global, Revenue Forecasts ($ m), 2000-2015 86Figure 68: Colorectal Cancer Therapeutics Market, Global, Volume (million), 2000-2015 87Figure 69: Colorectal Cancer Therapeutics Market, Global, Average Cost per Dose ($), 2000-2015 88Figure 70: Colorectal Cancer Therapeutics Market, Global, Drivers and Restraints, 89Figure 71: Colorectal Cancer Therapeutics Market, Global, Usage Patterns, 2000-2015 89Figure 72: Colorectal Cancer Therapeutics Market, Global, Diseased Population, 2000-2015 90Figure 73: Colorectal Cancer Therapeutics Market, Global, Treatment Seeking Population, 2000-2015 91Figure 74: Colorectal Cancer Therapeutics Market, Global, Diagnosis Population, 2000-2015 92Figure 75: Colorectal Cancer Therapeutics Market, Global, Prescription Population, 2000-2015 93Figure 76: Prostate Cancer Therapeutics Market, Global, Revenue ($m), 2000-2015 95Figure 77: Prostate Cancer Therapeutics Market, Global, Volume (million), 2000-2015 96The Future of Oncology Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis Page 8/12
  • 9. Find Industry reports, Company profilesReportLinker and Market StatisticsFigure 78: Prostate Cancer Therapeutics Market, Global, Average Cost per Dose ($), 2000-2015 97Figure 79: Prostate Cancer Therapeutics Market, Major Drivers and Restraints, 2008-2015 98Figure 80: Prostate Cancer Therapeutics Market, Global, Usage Patterns, 2000-2015 99Figure 81: Prostate Cancer Therapeutics Market, Global, Diseased Population, 2000-2015 100Figure 82: Prostate Cancer Therapeutics Market, Global, Treatment Seeking Population, 2000-2015 100Figure 83: Prostate Cancer Therapeutics Market, Global, Diagnosis Population, 2000-2015 101Figure 84: Prostate Cancer Therapeutics Market, Global, Prescription Population, 2000-2015 102Figure 85: Lung Cancer Therapeutics Market, Global, Revenue ($ m), 2000-2015 106Figure 86: Lung Cancer Therapeutics Market, Global, Volume (million), 2000-2015 107Figure 87: Lung Cancer Therapeutics Market, Global, Average Cost per Dose ($), 2000-2015 108Figure 88: Lung Cancer Therapeutics Market Major Drivers and Restraints 2008-2015 109Figure 89: Lung Cancer Therapeutics Market, Global, Usage Patterns, 2000-2015 109Figure 90: Lung Cancer Therapeutics Market, Global, Diseased Population, 2000-2015 110Figure 91: Lung Cancer Therapeutics Market, Global, Treatment Seeking Population, 2000-2015 111Figure 92: Lung Cancer Therapeutics Market, Global, Diagnosis Population, 2000-2015 112Figure 93: Lung Cancer Therapeutics Market, Global, Prescription Population, 2000-2015 113Figure 94: Oncology Therapeutics Market, Global, R&D Pipeline (Number and %), September 2009 114Figure 95: Oncology Therapeutics Market, Global, Strategies for Successful Product Launches in Cancer Market 115Figure 96: Oncology Therapeutics Market, Global, Cancer Tumors Segmented by their Market and Degree of Unmet Needs 116Figure 97: Oncology Therapeutics Market, Global, Top Three Companies Landscape, 2008 133Figure 98: Oncology Therapeutics Market, Global, Top 10 Companies Sales ($ m), 2006-08 134Figure 99: Oncology Therapeutics Market, Global, R&D Pipeline (NCE) of the Top 10 Companies, 2009 135Figure 100: Oncology Therapeutics Market, Global, Key Target Therapies Launched, 1998-2009 136Figure 101: Oncology Therapeutics Market, Global, Market Trends 137Figure 102: Oncology Therapeutics Market, Global, Market Share Analysis, 2008 138Figure 103: Oncology Therapeutics Market, Global, Top 5 Companies Benchmarking, 2008 138Figure 104: Oncology Therapeutics Market, Global, Top 10 Brands Sales ($ m), 2006-08 139Figure 105: Oncology Therapeutics Market, Global, Roche Oncology Drugs Segmentation, 2008 140Figure 106: Oncology Therapeutics Market, Global, Roche/Genentech Sales, 2006-15 141Figure 107: Oncology Therapeutics Market, Global, Roche/Genentech, Number of Products in Clinical Trails by Indication, June 2009145Figure 108: Oncology Therapeutics Market, Global, Roche/Genentech, Follow on Indications, June 2009 146Figure 109: Oncology Therapeutics Market, Global, Roche/Genentech, Phase-wise Analysis, June 2009 147Figure 110: Oncology Therapeutics Market, Global, Novartis, Sales ($ m), 2006-15 148Figure 111: Oncology Therapeutics Market, Global, Novartis, R&D Pipeline by Indication, June 2009 151Figure 112: Oncology Therapeutics Market, Global, Novartis, R&D Pipeline Phase-wise Analysis, June 2009 152Figure 113: Oncology Therapeutics Market, Global, Sanofi Aventis, Sales Segmentation by Brand ($ m) 2008 154Figure 114: Oncology Therapeutics Market, Global, Sanofi-Aventis, Sales ($ m), 2006-15 155Figure 115: Oncology Therapeutics Market, Global, Sanofi-Aventis, R&D Pipeline by Indication, June 2009 156Figure 116: Oncology Therapeutics Market, Global, Sanofi-Aventis, R&D Pipeline by Phase, June 2009 158Figure 117: Oncology Therapeutics Market, Global, Amgen, Sales Segmentation by Brand, 2008 159Figure 118: Oncology Therapeutics Market, Global, Amgen, Sales ($ m), 2006-15 160Figure 119: Oncology Therapeutics Market, Global, R&D Pipeline by Indication, June 2009 162Figure 120: Oncology Therapeutics Market, Global, Amgen, R&D Pipeline by Phase, June 2009 163Figure 121: Oncology Therapeutics Market, Global, AstraZeneca, Sales Segmentation by Brand, 2008 164Figure 122: Oncology Therapeutics Market, Global, AstraZeneca, Sales ($ m), 2006-2015 165Figure 123: Oncology Therapeutics Market, Global, R&D Pipeline by Indication, June 2009 167Figure 124: Oncology Therapeutics Market, Global, AstraZeneca, R&D Pipeline by Phase, June 2009 167Figure 125: Oncology Therapeutics Market, Global, Major M&A Deals, 2008-09 169Figure 126: Oncology Therapeutics Market, Global, Major Licensing Agreements By Each Phase, 2008-09 171The Future of Oncology Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis Page 9/12
  • 10. Find Industry reports, Company profilesReportLinker and Market StatisticsFigure 127: Oncology Therapeutics Market, Global, Major Licensing Agreements By Geography, 2008-09 172Figure 128: Oncology Therapeutics Market, Global, Major Licensing Agreements By Type, 2008-09 172Figure 129: Oncology Therapeutics Market, Global, Major Licensing Agreements By Value, 2008-09 173Figure 130: GBI Research Methodology 181The Future of Oncology Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis Page 10/12
  • 11. Find Industry reports, Company profilesReportLinker and Market Statistics Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93 If you have any questions please visit http://www.reportlinker.com/notify/contact Order Information Please verify that the product information is correct and select the format(s) you require. The Future of Oncology Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis Product Formats Please select the product formats and the quantity you require. 1 User License--USD 3 500.00 Quantity: _____ Site License--USD 7 000.00 Quantity: _____ Corporate License--USD 10 500.00 Quantity: _____ Contact Information Please enter all the information below in BLOCK CAPITALS Title: Mr Mrs Dr Miss Ms Prof First Name: _____________________________ Last Name: __________________________________ Email Address: __________________________________________________________________________ Job Title: __________________________________________________________________________ Organization: __________________________________________________________________________ Address: __________________________________________________________________________ City: __________________________________________________________________________ Postal / Zip Code: __________________________________________________________________________ Country: __________________________________________________________________________ Phone Number: __________________________________________________________________________ Fax Number: __________________________________________________________________________The Future of Oncology Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis Page 11/12
  • 12. Find Industry reports, Company profilesReportLinker and Market Statistics Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box. Payment by credit card Card Number: ______________________________________________ Expiry Date __________ / _________ CVV Number _____________________ Card Type (ex: Visa, Amex…) _________________________________ Payment by wire transfer Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189 Payment by check UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE Customer signature:   Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93The Future of Oncology Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis Page 12/12